insights_auto
Why is ALCOX up 4.75%?
Dive Deeperchevron_right
ALCOX:EPA
NicOx SA
€0.31
arrow_upward
+4.75%(+0.014) 1D
Oct 9, 5:35:31 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€0.31
High
€0.31
Low
€0.30
Mkt. cap
29.64M
Avg. vol.
170.04K
Volume
90.64K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
Open
€0.31
High
€0.31
Low
€0.30
Mkt. cap
29.64M
Avg. vol.
170.04K
Volume
90.64K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
News stories
From web sources and news partners
BigGo Finance
·
49 minutes ago
Dow extends gains, climbs back above 51,300 on tech buybacks; SpaceX briefly up 3%
36Kr
·
49 minutes ago
Can the US Stock Bull Market Still Continue? 2025 Outlook, Key Drivers & Future Trend Analysis
ChartMill
·
2 hours ago
These S&P500 stocks are gapping in today's session
The Motley Fool
·
36 minutes ago
I've Owned the Vanguard S&P 500 ETF for 6 Years. Here's Why I'm Not Selling.
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorBiotechnology
Websitenicox.com